lecanemabD-:

Ming Zou1, Shan-Shan Xu1, Shi-Guo Zhu1

  • 1Department of Neurology and Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

BMC geriatrics
|September 30, 2025
PubMed
概括

对阿尔茨海默病的莱卡内马布治疗可能会导致D-二次体水平升高,这表明血液凝块的潜在风险. 监测D-二聚物对于管理这些药物不良反应至关重要.